Steve Gruer
Medical · Riverside, CANPI 1760526263
Payments from drug & device makers
Across 269 payments — averaging $21.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$869
- GSK$771
- AstraZeneca$518
- CSL Behring$515
- Grifols USA, LLC$512
- Takeda Pharmaceuticals U.S.A., Inc.$458
- plus $2K from 18 others
What the payments were for
- Food & beverage$5,71297%
- Education$1953%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 50 | $869 |
| GSK | 41 | $771 |
| AstraZeneca | 23 | $518 |
| CSL Behring | 23 | $515 |
| Grifols USA, LLC | 20 | $512 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $458 |
| Novartis | 18 | $401 |
| Genentech USA, Inc. | 15 | $314 |
| Biocryst US Sales Co., LLC | 12 | $300 |
| Sanofi-aventis U.S. LLC | 2 | $195 |
| Regeneron Healthcare Solutions, Inc. | 8 | $147 |
| Ionis Pharmaceuticals, Inc. | 5 | $144 |
| Octapharma USA, Inc. | 5 | $139 |
| Pfizer | 7 | $136 |
| Kaleo, Inc. | 6 | $123 |
| Optinose US, Inc. | 4 | $81 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $81 |
| Amgen | 3 | $76 |
| Pharming Healthcare, Inc. | 1 | $24 |
| Mylan Specialty L.p. | 1 | $24 |
| Cycle Pharmaceuticals Inc | 1 | $23 |
| Nestle Healthcare Nutrition Inc. | 1 | $22 |
| Phadia US Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xembify$101
How this compares
$5,907 in reported general payments places this provider in the 85th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 13 | $76,208 |
| HyqviaIgg/Hyaluronidase,recombinant | 24 | $69,493 |
| XolairOmalizumab | 23 | $60,825 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 41 | $38,380 |
| Spiriva RespimatTiotropium Bromide | 21 | $11,769 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $7,434 |
| Azelastine Hcl | 190 | $6,616 |
| Arnuity ElliptaFluticasone Furoate | 16 | $6,395 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $3,796 |
| Qvar RedihalerBeclomethasone Dipropionate | 12 | $3,636 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 12 | $3,182 |
| Epinephrine | 12 | $2,644 |
| Fluticasone Propionate HfaFluticasone Propionate | 13 | $2,568 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 64 | $1,818 |
| Fluticasone Propionate | 101 | $1,719 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid, Hyqvia | $458 | $145,70137 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $771 | $52,20970 claims |
| Boehringer IngelheimSpiriva Respimat | $15 | $11,76921 claims |
| AstraZenecaSymbicort | $518 | $3,79613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 medical providers in California.
Other medical in Riverside
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.